Lipoproteins

"Lipoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes.

Descriptor ID	D008074
MeSH Number(s)	D10.532 D12.776.521
Concept/Terms	Lipoproteins Lipoproteins Lipoprotein Circulating Lipoproteins Lipoproteins, Circulating

Below are MeSH descriptors whose meaning is more general than "Lipoproteins".

Chemicals and Drugs [D]
Lipids [D10]
Lipoproteins [D10.532]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Lipoproteins [D12.776.521]

Below are MeSH descriptors whose meaning is related to "Lipoproteins".

Below are MeSH descriptors whose meaning is more specific than "Lipoproteins".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lipoproteins" by people in this website by year, and whether "Lipoproteins" was a major or minor topic of these publications.

Bar chart showing 71 publications over 28 distinct years, with a maximum of 7 publications in 2003 and 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	1	3	4
1995	0	1	1
1996	2	0	2
1997	1	0	1
1998	0	1	1
1999	2	1	3
2000	3	1	4
2001	2	0	2
2002	1	0	1
2003	6	1	7
2004	6	1	7
2005	3	1	4
2006	3	0	3
2007	1	0	1
2008	2	0	2
2009	2	1	3
2010	0	1	1
2011	2	2	4
2012	2	0	2
2013	3	0	3
2014	1	1	2
2015	1	2	3
2017	2	0	2
2018	0	1	1
2019	2	1	3
2020	1	1	2
2021	0	1	1
2022	0	1	1

Below are the most recent publications written about "Lipoproteins" by people in Profiles.

Hammad SM, Hunt KJ, Baker NL, Klein RL, Lopes-Virella MF. Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins. J Clin Lipidol. 2022 Mar-Apr; 16(2):173-183.

View in: PubMed
McLeese RH, Zhao J, Fu D, Yu JY, Brazil DP, Lyons TJ. Effects of modified lipoproteins on human trophoblast cells: a role in pre-eclampsia in pregnancies complicated by diabetes. BMJ Open Diabetes Res Care. 2021 01; 9(1).

View in: PubMed
Saaoud F, Wang J, Iwanowycz S, Wang Y, Altomare D, Shao Y, Liu J, Blackshear PJ, Lessner SM, Murphy EA, Wang H, Yang X, Fan D. Bone marrow deficiency of mRNA decaying protein Tristetraprolin increases inflammation and mitochondrial ROS but reduces hepatic lipoprotein production in LDLR knockout mice. Redox Biol. 2020 10; 37:101609.

View in: PubMed
Hammad SM, Twal WO, Arif E, Semler AJ, Klein RL, Nihalani D. Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins. Genes (Basel). 2020 02 07; 11(2).

View in: PubMed
Federizon J, Frye A, Huang WC, Hart TM, He X, Beltran C, Marcinkiewicz AL, Mainprize IL, Wills MKB, Lin YP, Lovell JF. Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes. Vaccine. 2020 01 22; 38(4):942-950.

View in: PubMed
Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Basu A, Hammad SM, Aston CE, Lyons TJ. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 10 01; 104(10):4743-4755.

View in: PubMed
Müller-Calleja N, Hollerbach A, Ritter S, Pedrosa DG, Strand D, Graf C, Reinhardt C, Strand S, Poncelet P, Griffin JH, Lackner KJ, Ruf W. Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis. Blood. 2019 10 03; 134(14):1119-1131.

View in: PubMed
Bowden KL, Dubland JA, Chan T, Xu YH, Grabowski GA, Du H, Francis GA. LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo. Arterioscler Thromb Vasc Biol. 2018 05; 38(5):1191-1201.

View in: PubMed
Iqbal J, Walsh MT, Hammad SM, Hussain MM. Sphingolipids and Lipoproteins in Health and Metabolic Disorders. Trends Endocrinol Metab. 2017 07; 28(7):506-518.

View in: PubMed
Brown WV, Handelsman Y, Martin SS, Morris PB. JCL roundtable: Future of the lipid laboratory: Choosing valuable measures among the lipoproteins (part 1). J Clin Lipidol. 2017 May - Jun; 11(3):587-595.

View in: PubMed

People

Explore

Similar Concepts

Top Journals